Fermer le menu


Member of Lyonbiopole


KUSTE BIOPHARMA is a biopharmaceutical Clinical Stage company recently founded by seasoned Life Sciences entrepreneurs, inheriting anti-inflammatory compounds locally released, that have achieved results in Phase 3 for eye and ears diseases. KUSTE BIOPHARMA is expanding the use of these molecules to inflammatory Uro-Gastro diseases whose medical needs are currently unmet, such as Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Existing data support also other possible developments, like Inflammatory Bowel Disease (IBD). KUSTE BIOPHARMA has closed a relevant financial round entering Phase 2 clinical studies on IC/PBS.


Strategic application domain: Human Medicine

Application market: Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on may 7th, 2020 - 5 employees



Tour Part-Dieu, 129 rue Servient 69326 Lyon Lyon cedex 3



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.